Cargando…

West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety

West Nile virus (WNV) is an arthropod-borne virus (arbovirus). It circulates in an enzootic cycle between ornithophilic mosquitoes as vectors and reservoirs and avian host species for amplification, but humans can be infected as accidental hosts. In most individuals, WNV infection remains silent, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Frank, Christina, Schmidt-Chanasit, Jonas, Ziegler, Ute, Lachmann, Raskit, Preußel, Karina, Offergeld, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421668/
https://www.ncbi.nlm.nih.gov/pubmed/36159956
http://dx.doi.org/10.1159/000525167
_version_ 1784777644293750784
author Frank, Christina
Schmidt-Chanasit, Jonas
Ziegler, Ute
Lachmann, Raskit
Preußel, Karina
Offergeld, Ruth
author_facet Frank, Christina
Schmidt-Chanasit, Jonas
Ziegler, Ute
Lachmann, Raskit
Preußel, Karina
Offergeld, Ruth
author_sort Frank, Christina
collection PubMed
description West Nile virus (WNV) is an arthropod-borne virus (arbovirus). It circulates in an enzootic cycle between ornithophilic mosquitoes as vectors and reservoirs and avian host species for amplification, but humans can be infected as accidental hosts. In most individuals, WNV infection remains silent, while 20% develop mild symptoms of West Nile fever, and only 1% develop neuroinvasive disease (WNND). Human WNV cases have been identified in Southern and Eastern Europe for more than 20 years, but until 2018, Germany was considered to be a non-endemic country. This changed when in the exceptionally warm summer of 2018, conditions for viral replication in mosquitoes were ideal, and the first WNV cases among birds and horses were identified. The widespread domestic Culex mosquitoes are efficient vectors for WNV. Autochthonous mosquito-borne WNV infections in humans were reported in all following years, indicating a continuous circulation in the affected areas of Central-East Germany. So far, no clear expansion of the affected areas is discernible but may develop. WNV is a transfusion-transmissible-infection, and donor deferral or testing of donations after a stay in an affected area are effective means to ensure transfusion safety. WNV transmissions via blood products often result in WNND due to the predisposing underlying medical conditions of transfusion recipients. From 2020 onwards, roughly 80% of all blood establishments in Germany tested their donations for WNV using nucleic acid amplification techniques in the transmission season. Altogether, 19 confirmed WNV infections were identified from 2020–2021. As long as effective and affordable pathogen reduction is not available for all blood components, WNV testing or donor deferral will be essential. In order to timely identify affected areas, combined results of human and veterinary surveillance are needed. Partnerships between public health experts, transfusion medicine specialists, veterinarians, and entomologists should be strengthened to ensure a One Health approach.
format Online
Article
Text
id pubmed-9421668
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-94216682022-09-23 West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety Frank, Christina Schmidt-Chanasit, Jonas Ziegler, Ute Lachmann, Raskit Preußel, Karina Offergeld, Ruth Transfus Med Hemother Research Article West Nile virus (WNV) is an arthropod-borne virus (arbovirus). It circulates in an enzootic cycle between ornithophilic mosquitoes as vectors and reservoirs and avian host species for amplification, but humans can be infected as accidental hosts. In most individuals, WNV infection remains silent, while 20% develop mild symptoms of West Nile fever, and only 1% develop neuroinvasive disease (WNND). Human WNV cases have been identified in Southern and Eastern Europe for more than 20 years, but until 2018, Germany was considered to be a non-endemic country. This changed when in the exceptionally warm summer of 2018, conditions for viral replication in mosquitoes were ideal, and the first WNV cases among birds and horses were identified. The widespread domestic Culex mosquitoes are efficient vectors for WNV. Autochthonous mosquito-borne WNV infections in humans were reported in all following years, indicating a continuous circulation in the affected areas of Central-East Germany. So far, no clear expansion of the affected areas is discernible but may develop. WNV is a transfusion-transmissible-infection, and donor deferral or testing of donations after a stay in an affected area are effective means to ensure transfusion safety. WNV transmissions via blood products often result in WNND due to the predisposing underlying medical conditions of transfusion recipients. From 2020 onwards, roughly 80% of all blood establishments in Germany tested their donations for WNV using nucleic acid amplification techniques in the transmission season. Altogether, 19 confirmed WNV infections were identified from 2020–2021. As long as effective and affordable pathogen reduction is not available for all blood components, WNV testing or donor deferral will be essential. In order to timely identify affected areas, combined results of human and veterinary surveillance are needed. Partnerships between public health experts, transfusion medicine specialists, veterinarians, and entomologists should be strengthened to ensure a One Health approach. S. Karger AG 2022-06-20 /pmc/articles/PMC9421668/ /pubmed/36159956 http://dx.doi.org/10.1159/000525167 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Research Article
Frank, Christina
Schmidt-Chanasit, Jonas
Ziegler, Ute
Lachmann, Raskit
Preußel, Karina
Offergeld, Ruth
West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety
title West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety
title_full West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety
title_fullStr West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety
title_full_unstemmed West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety
title_short West Nile Virus in Germany: An Emerging Infection and Its Relevance for Transfusion Safety
title_sort west nile virus in germany: an emerging infection and its relevance for transfusion safety
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421668/
https://www.ncbi.nlm.nih.gov/pubmed/36159956
http://dx.doi.org/10.1159/000525167
work_keys_str_mv AT frankchristina westnilevirusingermanyanemerginginfectionanditsrelevancefortransfusionsafety
AT schmidtchanasitjonas westnilevirusingermanyanemerginginfectionanditsrelevancefortransfusionsafety
AT zieglerute westnilevirusingermanyanemerginginfectionanditsrelevancefortransfusionsafety
AT lachmannraskit westnilevirusingermanyanemerginginfectionanditsrelevancefortransfusionsafety
AT preußelkarina westnilevirusingermanyanemerginginfectionanditsrelevancefortransfusionsafety
AT offergeldruth westnilevirusingermanyanemerginginfectionanditsrelevancefortransfusionsafety